Logo

coronavirus

Breaking news on coronavirus testing, with real-time reporting on assays to detect the SARS-CoV2 coronavirus, which causes COVID-19. 

Check out our Coronavirus Test Tracker for the latest information on the regulatory status of these tests in the US, European, and Asian markets.

Blu Biotech Sniffing Out Infections, Cancer With Multi-Disease Breathalyzer
Premium

The firm is developing a shoebox-size gas chromatography instrument that could be used for routine screenings and critical illness detection and monitoring.

Scripps Research, Cue Health Pair up for COVID Test-to-Treat Program for Immunocompromised
Premium

The Cue Health-sponsored ImmunoCare study is testing the value of giving immunocompromised people at-home tests, telemedicine, and prescription delivery.

Lucira Health, Sesame Partner on COVID-19 Test-to-Treat Program

Sesame will offer free telehealth consultations to patients who purchase Lucira's molecular COVID-19 test. 

Helix, CDC Partner to Study Genetics of Vaccine Effectiveness

The firm said the contract extends its public-private partnership with the US Centers for Disease Control and Prevention.

Aided by COVID-19 Funding, Firms Continued Developing Handheld Diagnostic Instruments in 2022
Premium

The lightweight, portable instruments coming onto the market employ promise to deliver test results closer to patients, potentially hastening treatments.

Dec 28, 2022

Visby Medical Nabs FDA EUA for POC Respiratory Panel Test

Dec 9, 2022

Long COVID Clues Found in Acute SARS-CoV-2 Infection Blood Samples

Dec 2, 2022

KSL Pulse Scientific to Distribute Lucira Health Home COVID-19, Flu Molecular Test in Canada

Nov 18, 2022

UCLA Team Uses Magnets, Microfluidics to Create Handheld Molecular Dx System
Premium

Nov 10, 2022

Cue Health Q3 Revenues Decline 69 Percent

Nov 8, 2022

PerkinElmer Q3 Revenues Drop 17 Percent, Diagnostics Off 39 Percent

Nov 3, 2022

Meta-Analyses Hint at Severe COVID-19 Risk Factors, Ties to Autoimmune Disease

Nov 3, 2022

UK Startup LEX Diagnostics Developing Ultra-Fast Low-Cost PCR for Infectious Disease Dx
Premium

Nov 2, 2022

Hologic Secures $19M BARDA Contract for COVID-19, Combination Assays

Oct 24, 2022

Roche Obtains FDA 510(k) Clearance for COVID-19 PCR Test

Oct 14, 2022

Lucira Health Makes Progress with STI Panel, Prepares Rollout of Digital Health Platform
Premium

Oct 10, 2022

Studies Unravel SARS-CoV-2 Protein Interactions With Human Proteins

Oct 5, 2022

Abacus Dx to Distribute Sense Biodetection Molecular COVID-19 Test in Australia, New Zealand

Sep 16, 2022

SARS-CoV-2 Genome Set Reveals Evolution, Spread in Africa

Sep 14, 2022

DiaSorin Gains FDA 510(k) Clearance for COVID-19 PCR Test

Sep 9, 2022

SARS-CoV-2 Sequence Analysis Points to Extensive Within-Host Viral Diversity

Aug 19, 2022

Penn State Portable Molecular COVID-19 Test Aims to Fill Gap Between Antigen and Molecular Tests
Premium

Aug 15, 2022

Ginkgo Bioworks, XpresCheck Receive $16M CDC Contract for SARS-CoV-2 Surveillance in US Airports

Aug 11, 2022

Lucira Health Receives Health Canada Authorization for At-Home COVID-19, Flu Test

Aug 4, 2022

Adaptive Biotechnologies Halts T-Detect Commercialization, Reports 13 Percent Q2 Revenue Growth
Premium

Breaking News
The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.